Eli Lilly, Wegovy and Zepbound

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of $499, down from $650, takes effect immediately.
Eli Lilly providing lower-priced Zepbound offerings
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self
Novo Nordisk cuts Wegovy prices, following similar move for Zepbound by Eli Lilly
Novo Nordisk said Wednesday it will sell Wegovy for $499 a month in cash to patients who can’t get the blockbuster weight-loss drug through insurance, a bid to reach consumers who can’t afford the $1,
Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.
Novo to Sell Weight-Loss Drug Wegovy Directly to Patients
Novo Nordisk A/S is following in rival Eli Lilly & Co.’s footsteps by selling its hit weight-loss drug Wegovy directly to US patients at a discount.
There’s a price war over weight-loss drugs as Wegovy cuts costs for monthly subscribers
Novo Nordisk is cutting prices on weight-loss drug Wegovy, a week after Eli Lilly did the same for rival Zepbound.
Novo Nordisk to sell obesity drug Wegovy direct to patients at lower price
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers chase market share.
Ex-New York Giants staffer: Eli Manning should not be involved in QB search
One former New York Giants staffer is adamant that team legend Eli Manning should not be involved in their current ...
Eli Lilly takes aim at weight-loss drug copies with new ad campaign
Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...
Eli Lilly plans to invest $27B to build four new US plants as tariffs loom
Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...
Girl Scouts Thin Mints get a festive St. Patrick's Day twist at Eli’s Cheesecake
Eli’s Cheesecake and the Girl Scouts of Greater Chicago and Northwest Indiana are teaming up on St. Patrick’s Day treat made with the popular cookies. The limited-edition treats, available while ...
Eli Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
African drugmaker Aspen says new Latam and Eli Lilly portfolio boosting earnings
Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...
Arkansas Times4h
Novelist Eli Cranor to host writing program at ATU for high school juniors and seniors
Know any teenagers who’ve got the writing bug? On April 18, Arkansas Tech University in Russellville is hosting its ...
MM&M1d
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
ARLnow.com1d
Ask Eli: 2025 home design trends
Some of the 2025 trends that are sticking around from previous years are the use of curves in furniture, color drenching ...
What Diego Pavia said about his Vanderbilt football return, Eli Stowers as spring practice opens
Vanderbilt football's Diego Pavia, who won an NCAA lawsuit, and Eli Stowers, a potential NFL draft prospect, return for 2025.